Early feasibility studies on climate-friendly albuterol inhaler completed

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 61 sec. here
  • 6 min. at publisher
  • 📊 Quality Score:
  • News: 38%
  • Publisher: 71%

CDMO News

Manufacturing,Research,Respiratory

DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler (pMDI) which shows comparable performance to Ventolin® HFA but with a significant reduction in greenhouse gas emissions.

May 11 2024Bespak DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler which shows comparable performance to Ventolin® HFA but with a significant reduction in greenhouse gas emissions.

The new formulation has the potential to revolutionize the treatment of respiratory disease by reducing the global warming potential impact of albuterol inhalers such as Ventolin, the most commonly prescribed inhaler type globally. It is expected to be commercialized by mid-2027 to meet the requirements of the US phasedown of fluorinated gases under the American Innovation and Manufacturing Act of 2020.

The innovative formulation is being developed by Bespak at its Research Triangle Park, NC research facility under the terms of an exclusive agreement with DevPro Biopharma. The new formulation contains Honeywell’s Solstice® Air cGMP), a hydrofluoroolefin propellant that has 99.9% less global warming potential than current HFAs and is in clinical development for pMDI products.

for albuterol pMDIs producing emissions equivalent to more than 200,000 passenger vehicles. There is an urgent need to develop a low-GWP albuterol pMDI to reduce the environmental impact of the life-saving inhalers patients need, without sacrificing performance or ease-of-use. Working with Bespak, we are excited about the results we have seen with DP007 showing comparable performance with Ventolin HFA.

Manufacturing Research Respiratory

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Age children start to show signs of autism and what to look forSpotting signs of autism early on and early intervention can greatly improve outcomes researchers have found
Source: EchoWhatsOn - 🏆 74. / 59 Read more »

Manor Lords pricing revealed as it launches in early accessEd has an interest in streaming, people and communities, and giving a voice to marginalised people.
Source: eurogamer - 🏆 68. / 61 Read more »

Manor Lords players probably need reminding it’s still in Early AccessThe game's not been out long, but a series of fairly negative reviews have prompted some thoughts on the Manor Lords Early Access.
Source: VideoGamerCom - 🏆 83. / 55 Read more »

Nico Rosberg’s ‘too early’ warning over possible Lewis Hamilton Mercedes replacement'Timing wise it's really too early for him, and especially too early for Toto...'
Source: Planet_F1 - 🏆 126. / 51 Read more »

Cancer awareness roadshow nurses visit Ayrshire to help spot disease earlyThe roadshow is part of Cancer Research UK’s continued commitment to making health information as accessible as possible to everyone.
Source: Daily_Record - 🏆 9. / 89 Read more »

Lawrence Stroll 'in early talks' to sell minority Aston Martin stakeChanges coming at Silverstone?
Source: Planet_F1 - 🏆 126. / 51 Read more »